Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.
Launched by HILLEL YAFFE MEDICAL CENTER · Aug 6, 2013
Trial Information
Current as of June 10, 2025
Unknown status
Keywords
ClinConnect Summary
Pomegranate contains a high concentration of vitamins ( C, B1, B2, B3, B5), potassium, Magnesium , Zinc and is a good source for polyphenols .Polyphenols molecules have been found to possess antioxidant properties and may effects the expression of different genes . Recent studies indicate that among foods that contain polyphenols, juice extracted from the pomegranate has the highest concentration of measurable polyphenols . Pomegranates have shown inhibitory effect on NF-κB and the MAP kinases JNK and ERK, which are critical steps in the cascade of events leading to inflammatory response. T...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • TMC of less than 5 million spermatogonia in native sperm and morphology less than 4% by Kruger criteria.
- Exclusion Criteria:
- • sensitivity to Pomegranate
About Hillel Yaffe Medical Center
Hillel Yaffe Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Located in Hadera, Israel, the center is committed to fostering cutting-edge scientific inquiry and collaboration across various medical disciplines. With a focus on patient safety and ethical standards, Hillel Yaffe Medical Center actively engages in the development of novel therapies and treatment modalities, aiming to enhance health outcomes and contribute to the global medical community. The center prides itself on its multidisciplinary approach, integrating expertise from experienced researchers and clinicians to drive impactful studies that address critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hadera, , Israel
Patients applied
Trial Officials
Einat Shalom-Paz, MD
Principal Investigator
Hillel Yaffe Medical center, IVF unit, Hadera, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials